Denis Fabre has joined The Blackstone Group as a Senior Managing Director. Based in London, he is responsible for the European healthcare franchise for Blackstone Advisory Partners.
John Studzinski, of Blackstone Advisory Partners, says: “Healthcare is a core sector for the Blackstone Group with a number of high profile investments such as Biomet, DJO Global and Catalent. Denis is a great addition to our global advisory business and we are delighted to have him on board.”
Fabre says: “Blackstone’s Advisory business has a first-rate reputation providing senior level independent advice to businesses and governments facing particularly difficult issues. The firm has a unique position in the industry and has been expanding its business, particularly in Asia and Europe, and I am pleased to be part of this impressive group.”
Fabre has extensive experience in the major subsectors of the healthcare industry including pharmaceuticals, medical technology, diagnostics, life sciences tools and healthcare services. Mr Fabre completed $90bn of M&A and capital raising assignments for a wide range of leading healthcare companies such as Sanofi Aventis, Merck, H Lundbeck, UCB, Siemens, Royal Philips, Smith & Nephew, Molnlycke, Dragerwerk and Labco. Prior to joining Blackstone Mr Fabre worked at Bankers Trust, Lehman Brothers, Bear Stearns, Deutsche Bank and UBS where he advised a broad range of healthcare corporates and private equity funds over the past 19 years. Fabre received his BA from HEC and his MBA from the Wharton School of the University of Pennsylvania.
